Table 1 from A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Authors:
- Andrew L. CovelerACAndrew L. Coveler
- Matthew J. ReilleyMRMatthew J. Reilley
- Mark ZalupskiMZMark Zalupski
- Teresa MacarullaTMTeresa Macarulla
- Christos FountzilasCFChristos Fountzilas
- Mariano Ponz-SarviséMPMariano Ponz-Sarvisé
- Adnan NagrialANAdnan Nagrial
- Nataliya V. UbohaNUNataliya V. Uboha
- Sophia FrentzasSFSophia Frentzas
- Michael OvermanMOMichael Overman
- Anne NoonanANAnne Noonan
- Wells A. MessersmithWMWells A. Messersmith
Open Access
- 15 October 2024
- other
- Published by American Association for Cancer Research (AACR)